Press Release: Omeros : Omeros Corporation Announces Availability on its Website of Materials Accompanying Narsoplimab Presentations at the 2025 Tandem Meetings
SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (Nasdaq: OMER) today announced the availability on its website of materials accompanying two presentations given at the 2025 Tandem Meetings the Transplantation & Cellular...
Read full article »
Omeros is a Wasington-based biopharmaceutical company that researches and develops small-molecule and protein therapeutics for the treatment of inflammation and CNS disorders.
Read more